GAIN Act Update: Antibiotic Pipeline Problem is Politically Ripe
This article was originally published in RPM Report
Executive Summary
As the PDUFA reauthorization process approaches, antibiotic drug development is poised as an area to see some legislative action. A recent workshop highlighted the interest in such action and evidence it may be effective.